In the past decade the US has seen a vast change in societal prejudices regarding pharmacology. Ten years ago, pharmacy stocks were skyrocketing and the medical community was somewhat of a lapdog for whatever the cute pharmacy reps were telling them.
If that wasn't enough to meet sales quotas, then weekend trips to conferences in exotic destinations usually resulting in getting physicians to begin writing scripts for the 'latest, greatest' drugs to come along. Old drugs were regarded with a generational snobbery which is often closely matching the same dates when patent protections expired. But recently we've seen several researchers bravely exploring the medical impacts of a raw and ancient herb called cannabis. Three physicians have impressed me more by their temperament and curiosity than by their medical breakthroughs. I want to introduce them to you. Two of them have been to Oklahoma recently and I have had private conversations with them. The other has spoken with people I know and trust. Watch the videos of their clinical presentations at conferences and see if you agree? |
|
Nigel O'MallyNigel heavily focuses on the medical research and drug policy topics at SoonerPolitics, from an international perspective & a background in homeopathic herbs and agrarian culture. Archives
March 2020
Categories |